Navigation Links
Wound Management Technologies, Inc. Announces FDA Clearance of 510k

FORT WORTH, Texas, Nov. 13 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today the 510k clearance of a new wound management product utilizing their patented hydrolyzed collagen technology.

The new addition to our product line (patent pending) combines hydrolyzed collagen with the healing properties of polysulfated glycosaminoglycan (PSGAG) and will initially be available in gel form. PSGAG enhances the absorptive capacity of the hydrolyzed collagen gel, making it appropriate for the management of exudative wounds. In addition, PSGAG has been shown to prepare the granulation tissue for epidermal migration by maintaining a uniform, low density granulation tissue more easily modified by the migrating epithelium thus improving the rate of epithelialization of a chronic wound and reducing scarring.

The product has been cleared and is indicated for topical use in the management of chronic and acute wounds and dermal ulcers including the management of:
-- Pressure Ulcers (Stages I-IV)

-- Venous Stasis Ulcers

-- Diabetic Ulcers

-- First and Second Degree Burns

-- Surgical Wounds

-- Traumatic wounds

-- Superficial Wounds

-- Ulcers resulting from arterial insufficiency

-- Grafted wounds and donor sites

"We are delighted with the FDA clearance of the hydrolyzed collagen with polysulfated glycosaminoglycan (PSGAG)," states Cathy Bradshaw, President of Wound Care Innovations. "This allows us to bring to the high margin, advanced wound care market, a product that utilizes our proven, patented hydrolyzed collagen and incorporates the distinctive characteristics of PSGAG to prepare the wound bed for re-epithelialization, wound closure."

Costs associated with wound care are significant, exceeding billions of dollars annually. "We are introducing a new, improved product which addresses the epithelialization of healing wounds and will be cost effective, patient ready and easy to use in all health care settings. The product is cost effective both in terms of direct and indirect costs. We are encouraged by initial test observations which promise improved clinical outcomes for the patient. Our expectations are high. We expect our hydrolyzed collagen with Polysulfated Glycosaminoglycan to contribute significantly to our growth moving forward."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans
2. New Web Site Offers Shirts with Custom-embroidered Aviator Wings for Veteran Military Pilots, Supports Families of the Wounded Fund
3. Penn State Program To Help Wounded Warriors
4. ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
5. Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
6. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
7. ULURU Inc. Announces Poster Presentations at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care
8. Livelihood Programs Help Heal War Wounds in Uganda
9. VA, DoD Electronically Hand Off Records of Wounded Patients
10. Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009
11. Association for the Advancement of Wound Care Leads World Health Organization Initiative to Establish Guidelines for Wound and Lymphedema Care
Post Your Comments:
(Date:10/12/2015)... ... October 12, 2015 , ... To help ... its charitable donation to the National Breast Cancer Foundation. The National Breast Cancer ... breast cancer through early detection, education, and support services. , The annual campaign ...
(Date:10/12/2015)... ... October 12, 2015 , ... SQM Group ... a contact channel benchmarking study. Be a part of this insightful ... for improving customer experience, customer journey, contact channel execution and intelligence, workforce optimization, ...
(Date:10/12/2015)... ... ... Holcomb – Kreithen Plastic Surgery and MedSpa, PLLC (“Holcomb – Kreithen”), one of ... Surgery University,” an educational series of mini seminars covering aesthetic and plastic surgery options, ... Saturday, October 24, 2015. , The goal of the event is to provide hands-on ...
(Date:10/12/2015)... ... October 12, 2015 , ... The Asthma and ... Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) for a new project ... , The project, entitled “Training Patients with Asthma to Understand and Participate in ...
(Date:10/12/2015)... ... October 12, 2015 , ... International law firm Greenberg ... with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be ... ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program. ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... New York , October 12, 2015 ... (FMI) delivers key insights on the global vital signs monitoring ... Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025." The ... at a healthy CAGR of 9.5% and 9.2% in terms ... to factors, regarding which FMI offers major insights in detail ...
(Date:10/12/2015)... Oct. 12, 2015 Beginning October 1, 2015 ... Partner, the fastest growing practice management system for therapists, ... easily converts all patient diagnostic codes from the former ... --> --> Therapy Partner has ... mental health practitioners to easily understand the conversion to ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: INDV) ... of Delaware granted the Company,s motion ... Abbreviated New Drug Application (ANDA) No. 205299 to market a ... and naloxone) Sublingual Film (CIII) in the United ... Since August 2013, Indivior has received Paragraph IV certifications ...
Breaking Medicine Technology: